Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Drug Design, Development and Therapy | journal | 0.640 Q2 | 94 | 38 | 84 | 3421 | 232 | 82 | 3.11 | 90.03 | |
2 | Infection and Drug Resistance | journal | 0.123 Q4 | 65 | 24 | 9 | 1292 | 2 | 8 | 0.22 | 53.83 | |
3 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.168 Q3 | 64 | 15 | 36 | 640 | 26 | 35 | 0.72 | 42.67 | |
4 | Biomarker Insights | journal | 0.525 Q2 | 40 | 17 | 82 | 571 | 148 | 81 | 2.64 | 33.59 | |
5 | Pharmacogenomics and Personalized Medicine | journal | 0.147 Q4 | 37 | 11 | 20 | 1128 | 9 | 20 | 0.45 | 102.55 | |
6 | Drug, Healthcare and Patient Safety | journal | 0.165 Q3 | 30 | 16 | 35 | 598 | 22 | 33 | 0.63 | 37.38 | |
7 | Core Evidence (discontinued) | journal | 0.237 Q3 | 29 | 7 | 49 | 314 | 63 | 47 | 1.84 | 44.86 | |
8 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | |
9 | Perspectives in Medicinal Chemistry | journal | 0.785 Q2 | 17 | 2 | 13 | 81 | 36 | 13 | 4.50 | 40.50 | |
10 | Journal of Receptor, Ligand and Channel Research | journal | 0.659 Q2 | 13 | 5 | 5 | 394 | 14 | 5 | 2.80 | 78.80 | |
11 | Clinical Medicine Insights: Therapeutics | journal | 0.113 Q4 | 11 | 44 | 39 | 2873 | 9 | 39 | 0.23 | 65.30 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®